4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-25-003654
CVP, Chief Financial Officer sold 11,250 shares at $70.87 ($797,267)
- CVP, Chief Financial Officer acquired 11,250 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ullem Scott B. · CVP, Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +11,250 | $45.28 | $509,363 | 41,637 | D |
| 2025-03-26 | Sale : show line 2 in the form 10b5-1 | −11,250 | $70.87 | $797,267 | 30,387 | D |
| Open-market sales · 11,250 sh · avg $70.87 · $797,267 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-26 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −11,250 | 11,250 | D |
Loading xslF345X05/doc4.xml…